Related Experiment Video

Updated: Aug 12, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Inhibition of the mutant p53 gene in transformation assays

S W Beenken1, L Raycroft, G Lozano

  • 1Department of Surgery, University of Alabama, Birmingham 35294.

The Journal of Surgical Research
|April 1, 1992
PubMed

Insights

Mutations in the p53 gene are crucial for cancer development. Protein binding to intron 4 of the p53 gene is essential for its optimal expression and influences malignant transformation.

Area of Science:

  • Molecular Biology
  • Cancer Genetics

Background:

  • The p53 gene plays a critical role in preventing cancer, and its mutations are common in human malignancies.
  • Intron 4, a noncoding region of the p53 gene, is vital for its proper expression.
  • Previous research identified a nuclear protein that binds to intron 4 at a specific site.

Purpose of the Study:

  • To investigate whether the malignant transformation capability of a mutant p53 gene relies on protein binding to intron 4.
  • To determine the impact of alterations in the intron 4 protein-binding site on the cooperative transformation of cells with the Ha-ras oncogene.

Main Methods:

  • An in vitro cell transformation assay was employed using rat embryo fibroblasts.
  • Cells were co-transfected with mutant mouse p53 gene constructs (with and without modifications at the intron 4 binding site) and the Ha-ras oncogene.
  • Malignant transformation was assessed by counting foci of heaped-up cells after 14 days of incubation.

Main Results:

  • Co-transfection with mutant p53 and Ha-ras induced malignant transformation, evidenced by focus formation.
  • Introducing two base pair substitutions at the intron 4 protein-binding site significantly reduced the number of foci formed (P < 0.05).

Conclusions:

  • Protein binding to intron 4 of the p53 gene is critical for the malignant transformation of cells.
  • Disrupting the intron 4 protein-binding site diminishes the oncogenic potential of mutant p53.
  • These findings highlight the importance of noncoding regulatory elements in gene function and cancer development.

More Related Videos

Purification of Ubiquitinated p53 Proteins from Mammalian Cells10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...